Form D · Pharmaceuticals
Hs Pharmaceuticals LLC
Greenville, SC · CIK 0001355028
Offering snapshot reported Mar 18, 2009 · SEC filing
- Reported sold
- $8.55M Offering amount: $10.3M
- Investors reported
- Not reported Form D · investor count
- Minimum accepted
- Not reported Reported outside-investor minimum
- First sale
- Not reported As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 18, 2009 | Initial | $8,551,655 | No comparison | Not reported | SEC filing |
| Apr 9, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- Not reported
- Duration over one year
- Not reported
- Business combination
- Not reported
- Sales commissions
- Not reported
- Finders' fees
- Not reported
- Form D file number
- 021-116984
Source: Form D, filed Mar 18, 2009. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Rusty Rohrbaugh | Executive |
| Vincent Sordello | Executive |
| R Thomas Stanley | Director, Executive |
| Jon R Wilken | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
330 East Coffee St
Greenville, SC, 26901
Greenville, SC, 26901